Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease
Top Cited Papers
Open Access
- 11 February 2019
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 73 (6), 667-679
- https://doi.org/10.1016/j.jacc.2018.11.039
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery)КАРДИОЛОГИЯ УЗБЕКИСТАНА, 2015
- Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery DiseaseCirculation, 2015
- Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal LesionsJournal of Endovascular Therapy, 2014
- Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal LesionsJournal of the American College of Cardiology, 2013
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011
- Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee:Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical StudyJournal of Endovascular Therapy, 2011
- Polymer-free Paclitaxel-coated Zilver PTX Stents—Evaluation of Pharmacokinetics and Comparative Safety in Porcine ArteriesJournal of Vascular and Interventional Radiology, 2011
- Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal ArteryCirculation: Cardiovascular Interventions, 2010
- Clinical Trials for ClaudicationCirculation, 1995